- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Heart failure
- Meeting Date: July 2021
- Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 1346KB)
- Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 140KB)
Dapagliflozin – July 2021
Dapagliflozin (heart failure): Tablet 10 mg; Forxiga®
Last updated
12 November 2021